(Q38958802)

English

C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine

scientific article published on 22 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Sonya L Cyr

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Taff Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ioana Stoica-Popescu

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

David Burt

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Brian J Ward

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

22 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

3228-3232

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Protollin: a novel adjuvant for intranasal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

Immunity and immunopathology to respiratory syncytial virus. The mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.01.037

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38958802&oldid=1799140646"